189 related articles for article (PubMed ID: 34564895)
1. Differences in insulin sensitivity in the partial remission phase of childhood type 1 diabetes; a longitudinal cohort study.
Mørk FCB; Madsen JOB; Jensen AK; Hall GV; Pilgaard KA; Pociot F; Johannesen J
Diabet Med; 2022 Feb; 39(2):e14702. PubMed ID: 34564895
[TBL] [Abstract][Full Text] [Related]
2. New definition for the partial remission period in children and adolescents with type 1 diabetes.
Mortensen HB; Hougaard P; Swift P; Hansen L; Holl RW; Hoey H; Bjoerndalen H; de Beaufort C; Chiarelli F; Danne T; Schoenle EJ; Aman J;
Diabetes Care; 2009 Aug; 32(8):1384-90. PubMed ID: 19435955
[TBL] [Abstract][Full Text] [Related]
3. Partial remission definition: validation based on the insulin dose-adjusted HbA1c (IDAA1C) in 129 Danish children with new-onset type 1 diabetes.
Max Andersen ML; Hougaard P; Pörksen S; Nielsen LB; Fredheim S; Svensson J; Thomsen J; Vikre-Jørgensen J; Hertel T; Petersen JS; Hansen L; Mortensen HB
Pediatr Diabetes; 2014 Nov; 15(7):469-76. PubMed ID: 25287319
[TBL] [Abstract][Full Text] [Related]
4. Partial clinical remission in type 1 diabetes: a comparison of the accuracy of total daily dose of insulin of <0.3 units/kg/day to the gold standard insulin-dose adjusted hemoglobin A1c of ≤9 for the detection of partial clinical remission.
Lundberg RL; Marino KR; Jasrotia A; Maranda LS; Barton BA; Alonso LC; Nwosu BU
J Pediatr Endocrinol Metab; 2017 Aug; 30(8):823-830. PubMed ID: 28753540
[TBL] [Abstract][Full Text] [Related]
5. Bone turnover markers during the remission phase in children and adolescents with type 1 diabetes.
Madsen JOB; Herskin CW; Zerahn B; Jensen AK; Jørgensen NR; Olsen BS; Svensson J; Pociot F; Johannesen J
Pediatr Diabetes; 2020 Mar; 21(2):366-376. PubMed ID: 31840392
[TBL] [Abstract][Full Text] [Related]
6. Partial Clinical Remission of Type 1 Diabetes: The Need for an Integrated Functional Definition Based on Insulin-Dose Adjusted A1c and Insulin Sensitivity Score.
Nwosu BU
Front Endocrinol (Lausanne); 2022; 13():884219. PubMed ID: 35592786
[TBL] [Abstract][Full Text] [Related]
7. Factors contributing to partial remission in type 1 diabetes: analysis based on the insulin dose-adjusted HbA1c in 3657 children and adolescents from Germany and Austria.
Nagl K; Hermann JM; Plamper M; Schröder C; Dost A; Kordonouri O; Rami-Merhar B; Holl RW
Pediatr Diabetes; 2017 Sep; 18(6):428-434. PubMed ID: 27416952
[TBL] [Abstract][Full Text] [Related]
8. Partial remission in type 1 diabetes and associated factors: Analysis based on the insulin dose-adjusted hemoglobin A1c in children and adolescents from a regional diabetes center, Auckland, New Zealand.
Chiavaroli V; Derraik JGB; Jalaludin MY; Albert BB; Ramkumar S; Cutfield WS; Hofman PL; Jefferies CA
Pediatr Diabetes; 2019 Nov; 20(7):892-900. PubMed ID: 31237756
[TBL] [Abstract][Full Text] [Related]
9. Partial remission in children and adolescents with type 1 diabetes: an analysis based on the insulin dose-adjusted hemoglobin A1c.
Cimbek EA; Bozkır A; Usta D; Beyhun NE; Ökten A; Karagüzel G
J Pediatr Endocrinol Metab; 2021 Oct; 34(10):1311-1317. PubMed ID: 34271601
[TBL] [Abstract][Full Text] [Related]
10. Complete remission in children and adolescents with type 1 diabetes mellitus-prevalence and factors.
Podolakova K; Barak L; Jancova E; Tarnokova S; Podracka L; Dobiasova Z; Skopkova M; Gasperikova D; Stanik J
Sci Rep; 2023 Apr; 13(1):6790. PubMed ID: 37100887
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes in youth beyond the first year of type 1 diabetes: Results of the Pediatric Diabetes Consortium (PDC) type 1 diabetes new onset (NeOn) study.
Cengiz E; Cheng P; Ruedy KJ; Kollman C; Tamborlane WV; Klingensmith GJ; Gal RL; Silverstein J; Lee J; Redondo MJ; Beck RW;
Pediatr Diabetes; 2017 Nov; 18(7):566-573. PubMed ID: 27758023
[TBL] [Abstract][Full Text] [Related]
12. The remission phase in adolescents and young adults with newly diagnosed type 1 diabetes mellitus: prevalence, predicting factors and glycemic control during follow-up.
Yazidi M; Mahjoubi S; Oueslati I; Chaker F; Chihaoui M
Arch Endocrinol Metab; 2022 Apr; 66(2):222-228. PubMed ID: 35315990
[TBL] [Abstract][Full Text] [Related]
13. Individual and diabetes presentation characteristics associated with partial remission status in children and adults evaluated up to 12 months following diagnosis of type 1 diabetes: An ADDRESS-2 (After Diagnosis Diabetes Research Support System-2) study analysis.
Humphreys A; Bravis V; Kaur A; Walkey HC; Godsland IF; Misra S; Johnston DG; Oliver NS
Diabetes Res Clin Pract; 2019 Sep; 155():107789. PubMed ID: 31326456
[TBL] [Abstract][Full Text] [Related]
14. Correlation Among Hypoglycemia, Glycemic Variability, and C-Peptide Preservation After Alefacept Therapy in Patients with Type 1 Diabetes Mellitus: Analysis of Data from the Immune Tolerance Network T1DAL Trial.
Pinckney A; Rigby MR; Keyes-Elstein L; Soppe CL; Nepom GT; Ehlers MR
Clin Ther; 2016 Jun; 38(6):1327-1339. PubMed ID: 27209482
[TBL] [Abstract][Full Text] [Related]
15. Partial remission phase and metabolic control in type 1 diabetes mellitus in children and adolescents.
Böber E; Dündar B; Büyükgebiz A
J Pediatr Endocrinol Metab; 2001 Apr; 14(4):435-41. PubMed ID: 11327378
[TBL] [Abstract][Full Text] [Related]
16. An improved clinical model to predict stimulated C-peptide in children with recent-onset type 1 diabetes.
Buchanan K; Mehdi AM; Hughes I; Cotterill A; Le Cao KA; Thomas R; Harris M
Pediatr Diabetes; 2019 Mar; 20(2):166-171. PubMed ID: 30556344
[TBL] [Abstract][Full Text] [Related]
17. Markers influencing the presence of partial clinical remission in patients with newly diagnosed type 1 diabetes.
Pyziak A; Zmyslowska A; Bobeff K; Malachowska B; Fendler W; Wyka K; Baranowska-Jazwiecka A; Szymanska M; Szadkowska A; Mlynarski W
J Pediatr Endocrinol Metab; 2017 Oct; 30(11):1147-1153. PubMed ID: 29016353
[TBL] [Abstract][Full Text] [Related]
18. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
[TBL] [Abstract][Full Text] [Related]
19. Early weight gain after diagnosis may have an impact on remission status in children with new-onset type 1 diabetes mellitus.
Emet DC; Karavar HN; Gozmen O; Agyar AA; Ünsal Y; Canturk M; Cengiz P; Vuralli D; Ozon ZA; Gonc EN
J Diabetes; 2023 Dec; 15(12):1011-1019. PubMed ID: 37572062
[TBL] [Abstract][Full Text] [Related]
20. A predictive model for lack of partial clinical remission in new-onset pediatric type 1 diabetes.
Marino KR; Lundberg RL; Jasrotia A; Maranda LS; Thompson MJ; Barton BA; Alonso LC; Nwosu BU
PLoS One; 2017; 12(5):e0176860. PubMed ID: 28459844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
